The Journal of Organic Chemistry
Article
1
3
114.8, 55.4; 19F NMR (471 MHz, CDCl3) δ −68.0 (s); HRMS (ESI)
m/z [M + H]+ calcd for C19H15F3NO+ 330.1100, found 330.1103.
4-(4-Fluorophenyl)-2-phenyl-6-(trifluoromethyl)pyridine (3da).
The compound (29.3 mg, 46%) was prepared from the general
procedure (ethyl acetate/petroleum ether = 1:300 → 1:80, v/v) as a
127.2, 125.3, 120.7, 121.5 (q, JC−F = 275 Hz), 116.6 (q, JC−F = 3
Hz); 19F NMR (471 MHz, CDCl3) δ −67.9 (s); HRMS (ESI) m/z
[M + H]+ calcd for C18H12ClF3N+ 334.0605, found 334.0608.
2-Phenyl-4-(o-tolyl)-6-(trifluoromethyl)pyridine (3ja). The com-
pound (22.3 mg, 35%) was prepared from the general procedure
(ethyl acetate/petroleum ether = 1:300 → 1:100, v/v) as a yellow
solid: mp = 70−72 °C; 1H NMR (500 MHz, CDCl3) δ 8.09 (dd, J =
7.8, 1.6 Hz, 2H), 7.86 (s, 1H), 7.58 (d, J = 1.4 Hz, 1H), 7.53−7.42
(m, 3H), 7.39−7.29 (m, 3H), 7.26 (dd, J = 7.6, 1.4 Hz, 1H), 2.32 (s,
3H); 13C{1H} NMR (126 MHz, CDCl3) δ 157.8, 152.3, 148.2 (q,
2JC−F = 34 Hz), 138.3, 137.9, 135.0, 130.9, 129.8, 129.2, 129.0, 128.9,
1
yellow solid; mp = 96−98 °C; H NMR (500 MHz, CDCl3) δ 8.10
(dd, J = 7.8, 1.5 Hz, 2H), 8.03 (s, 1H), 7.76 (d, J = 1.5 Hz, 1H),
7.71−7.67 (m, 2H), 7.55−7.44 (m, 3H), 7.23 (dd, J = 8.4, 1.8 Hz,
2H); 13C{1H} NMR (126 MHz, CDCl3) δ 163.9 (d, 1JC−F = 246 Hz),
162.8 (d, 5JC−F = 2 Hz), 158.6, 149.9, 149.0 (q, 2JC−F = 34 Hz), 133.6
(d, 4JC−F = 3 Hz), 129.9, 129.0 (d, 3JC−F = 9 Hz), 128.9, 127.2, 121.7
(q, 1JC−F = 275 Hz), 120.6, 117.3 (q, 3JC−F = 3 Hz), 116.4 (d, 2JC−F
=
1
3
127.2, 126.3, 123.3, 124.1 (q, JC−F = 275 Hz), 119.2 (q, JC−F = 3
Hz), 20.2; 19F NMR (471 MHz, CDCl3) δ −67.9 (s); HRMS (ESI)
m/z [M + H]+ calcd for C19H15F3N+ 314.1151, found 314.1151.
4-(2-Fluorophenyl)-2-phenyl-6-(trifluoromethyl)pyridine (3ka).
The compound (30.0 mg, 47%) was prepared from the general
procedure (ethyl acetate/petroleum ether = 1:300 → 1:80, v/v) as a
22 Hz); 19F NMR (471 MHz, CDCl3) δ −68.0 (s), −(111.2−111.3)
(m); HRMS (ESI) m/z [M + Na]+ calcd for C18H11F4Na+ 340.0720,
found 340.0721.
4-(4-Chlorophenyl)-2-phenyl-6-(trifluoromethyl)pyridine (3ea).
The compound (31.0 mg, 46%) was prepared from the general
procedure (ethyl acetate/petroleum ether = 1:300 → 1:80, v/v) as a
1
yellow solid: mp = 49−50 °C; H NMR (500 MHz, CDCl3) δ 8.09
1
yellow solid: mp = 90−91 °C; H NMR (500 MHz, CDCl3) δ 8.09
(dd, J = 7.8, 1.6 Hz, 2H), 8.07 (s, 1H), 7.78 (s, 1H), 7.55−7.43 (m,
5H), 7.30 (ddd, J = 7.6, 7.6, 1.2 Hz, 1H), 7.26−7.20 (m, 1H).
(dd, J = 7.8, 1.6 Hz, 2H), 8.03 (d, J = 1.4 Hz, 1H), 7.75 (d, J = 1.4 Hz,
1H), 7.63 (d, J = 8.4, 1.8 Hz, 2H), 7.53−7.46 (m, 5H); 13C{1H}
13C{1H} NMR (126 MHz, CDCl3) δ 159.8 (d, J = 246 Hz), 158.2,
1
2
148.5 (q, 2JC−F = 34 Hz), 145.9, 137.8, 131.4 (d, 3JC−F = 9 Hz), 130.2
(d, 4JC−F = 3 Hz), 129.8, 128.9, 127.2, 125.5 (d, 2JC−F = 13 Hz), 125.0
(d, 4JC−F = 4 Hz), 122.8 (d, 4JC−F = 4 Hz), 121.7 (q, 1JC−F = 275 Hz),
NMR (126 MHz, CDCl3) δ 158.6, 149.7, 148.9 (q, JC−F = 34 Hz),
1
137.7, 136.1, 135.8, 129.9, 129.6, 128.9, 128.4, 127.2, 121.7 (q, JC−F
3
= 275 Hz), 120.5, 116.5 (d, JC−F = 3 Hz); 19F NMR (471 MHz,
CDCl3) δ −68.0 (s); HRMS (ESI) m/z [M + H]+ calcd for
118.5 (q, JC−F = 3 Hz), 116.6 (d, JC−F = 22 Hz); 19F NMR (471
MHz, CDCl3) δ −67.9 (s), −(116.8−116.9) (m); HRMS (ESI) m/z
[M + H]+ calcd for C18H12F4N+ 318.0900, found 318.0898.
3
2
C18H12ClF3N+ 334.0605, found 334.0601.
2-Phenyl-6-(trifluoromethyl)-4-{4-(trifluoromethyl)phenyl}-
pyridine (3fa). The compound (31.0 mg, 42%) was prepared from
the general procedure (ethyl acetate/petroleum ether = 1:300 →
1:80, v/v) as a yellow solid: mp = 101−102 °C; 1H NMR (500 MHz,
CDCl3) δ 8.11 (dd, J = 6.7, 1.8 Hz, 2H), 8.07 (s, 1H), 7.80−7.79 (m,
5H), 7.54−7.44 (m, 3H); 13C{1H} NMR (126 MHz, CDCl3) δ 158.8,
2-Phenyl-4-(thiophen-2-yl)-6-(trifluoromethyl)pyridine (3la). The
compound (27.2 mg, 45%) was prepared from the general procedure
(ethyl acetate/petroleum ether = 1:300 → 1:80, v/v) as a yellow
solid: mp = 102−103 °C; 1H NMR (500 MHz, CDCl3) δ 8.08 (dd, J
= 7.8, 1.5 Hz, 2H), 8.02 (s, 1H), 7.76 (d, J = 1.4 Hz, 1H), 7.61 (dd, J
= 3.7, 1.2 Hz, 1H), 7.54−7.44 (m, 4H), 7.18 (dd, J = 5.2, 3.6 Hz,
1H); 13C{1H} NMR (126 MHz, CDCl3) δ 158.7, 149.0 (q, 2JC−F = 34
Hz), 143.9, 140.2, 137.8, 129.9, 128.9, 128.7, 128.1, 127.2, 126.3,
2
2
149.6, 149.0 (q, JC−F = 34 Hz), 141.0, 137.6, 131.7 (q, JC−F = 34
3
Hz), 130.1, 129.0, 127.7, 127.2, 126.3 (q, JC−F = 4 Hz), 124.0 (q,
1JC−F = 270 Hz), 121.5 (q, 1JC−F = 275 Hz), 120.9, 116.8 (q, 3JC−F = 3
Hz); 19F NMR (471 MHz, CDCl3) δ −62.7 (s), −68.0 (s); HRMS
(ESI) m/z [M + H]+ calcd for C19H12F6N+ 368.0868, found
368.0864.
121.4 (q, JC−F = 275 Hz), 118.8, 114.9 (q, JC−F = 3 Hz); 19F NMR
(471 MHz, CDCl3) δ −68.1 (s); HRMS (ESI) m/z [M + H]+ calcd
for C16H11F3SN+ 306.0559, found 306.0560.
1
3
2-Phenyl-4-(m-tolyl)-6-(trifluoromethyl)pyridine (3ga). The com-
pound (26.1 mg, 41%) was prepared from the general procedure
(ethyl acetate/petroleum ether = 1:300 → 1:100, v/v) as a yellow
solid: mp = 78−80 °C; 1H NMR (500 MHz, CDCl3) δ 8.09 (dd, J =
7.8, 1.4 Hz, 2H), 7.86 (s, 1H), 7.58 (s, 1H), 7.52−7.42 (m, 3H),
7.39−7.29 (m, 3H), 7.26 (dd, J = 7.6 Hz, 1H), 2.32 (s, 3H); 13C{1H}
4-Phenyl-2-(p-tolyl)-6-(trifluoromethyl)pyridine (3ab). The com-
pound (41.0 mg, 65%) was prepared from the general procedure
(ethyl acetate/petroleum ether = 1:300 → 1:100, v/v) as a yellow
1
solid; mp = 89−90 °C; H NMR (500 MHz, CDCl3) δ 8.04 (d, J =
1.4 Hz, 1H), 8.01 (d, J = 8.1 Hz, 2H), 7.76 (d, J = 1.4 Hz, 1H), 7.71−
7.66 (m, 2H), 7.56−7.46 (m, 3H), 7.30 (d, J = 8.0 Hz, 2H), 2.41 (s,
3H); 13C{1H} NMR (126 MHz, CDCl3) δ 161.1, 158.4, 150.9, 148.6
2
NMR (126 MHz, CDCl3) δ 158.4, 150.8, 148.7 (q, JC−F = 34 Hz),
2
140.0, 138.0, 137.5, 135.1, 134.4, 130.0, 129.7, 128.8, 127.2, 126.9,
(q, JC−F = 34 Hz), 140.0, 137.5, 135.2, 129.6, 129.6, 129.3, 127.1,
1
3
120.5, 121.6 (q, JC−F = 275 Hz), 116.4 (q, JC−F = 3 Hz), 21.2; 19F
NMR (471 MHz, CDCl3) δ −67.9 (s); HRMS (ESI) m/z [M + H]+
calcd for C19H15F3N+ 314.1151, found 314.1149.
1
3
127.1, 121.6 (q, JC−F = 275 Hz), 116.4 (q, JC−F = 3 Hz), 21.3; 19F
NMR (471 MHz, CDCl3) δ −67.9 (s); HRMS (ESI) m/z [M + H]+
calcd for C19H15F3N+ 314.1151, found 314.1152.
4-(3-Fluorophenyl)-2-phenyl-6-(trifluoromethyl)pyridine (3ha).
The compound (29.2 mg, 46%) was prepared from the general
procedure (ethyl acetate/petroleum ether = 1:300 → 1:80, v/v) as a
2-(4-Methoxyphenyl)-4-phenyl-6-(trifluoromethyl)pyridine (3ac).
The compound (30.2 mg, 45%) was prepared from the general
procedure (ethyl acetate/petroleum ether = 1:300 → 1:80, v/v) as a
1
1
yellow solid: mp = 90−91 °C; H NMR (500 MHz, CDCl3) δ 8.10
yellow solid: mp = 92−94 °C; H NMR (500 MHz, CDCl3) δ 8.08
(dd, J = 8.9, 5.4 Hz, 2H), 8.02 (s, 1H), 7.79 (d, J = 1.4 Hz, 1H),
7.72−7.67 (m, 2H), 7.56−7.50 (m, 3H), 7.18 (dd, J = 8.6, 8.6 Hz,
2H); 13C{1H} NMR (126 MHz, CDCl3) δ 165.0 (d, 1JC−F = 246 Hz),
157.4, 151.2, 148.8 (q, 2JC−F = 34 Hz), 137.3, 134.1 (d, 4JC−F = 3 Hz),
(dd, J = 8.8, 1.6 Hz, 2H), 8.01 (d, J = 1.4 Hz, 1H), 7.74 (d, J = 1.4 Hz,
1H), 7.69 (dd, J = 7.8, 1.5 Hz, 2H), 7.58−7.46 (m, 3H), 7.02 (dd, J =
8.8, 1.6 Hz, 2H), 3.87 (s, 3H); 13C{1H}NMR (126 MHz, CDCl3) δ
2
161.1, 158.1, 150.8, 148.6 (q, JC−F = 34 Hz), 137.6, 130.5, 129.6,
3
1
129.3, 128.6, 127.1, 120.0, 121.1 (q, 1JC−F = 275 Hz), 116.1 (q, 3JC−F
= 3 Hz), 114.2, 55.4; 19F NMR (471 MHz, CDCl3) δ −68.0 (s);
HRMS (ESI) m/z [M + H]+ calcd for C19H15F3NO+ 330.1100, found
330.1103.
129.8, 129.3, 129.1 (d, JC−F = 9 Hz), 127.1, 121.6 (q, JC−F = 275
Hz), 120.4, 116.6 (q, 3JC−F = 3 Hz), 116.5 (d, 4JC−F = 3 Hz), 116.4 (d,
2JC−F = 22 Hz), 115.9 (d, JC−F = 22 Hz); 19F NMR (471 MHz,
2
CDCl3) δ −68.0 (s), −(109.6−115.0) (m); HRMS (ESI) m/z [M +
H]+ calcd for C18H12F4N+ 318.0900, found 318.0905.
2-(4-Fluorophenyl)-4-phenyl-6-(trifluoromethyl)pyridine (3ad).
The compound (25.3 mg, 40%) was prepared from the general
procedure (ethyl acetate/petroleum ether = 1:300 → 1:80, v/v) as a
yellow solid: mp = 98−100 °C; 1H NMR (500 MHz, CDCl3) δ 8.08
(s, 1H), 7.95−7.84 (m, 3H), 7.69 (dd, J = 7.8, 1.4 Hz, 2H), 7.62−
7.45 (m, 4H), 7.14 (dd, J = 8.4, 8.4, 2.3 Hz, 1H); 13C{1H} NMR (126
4-(3-Chlorophenyl)-2-phenyl-6-(trifluoromethyl)pyridine (3ia).
The compound (30.0 mg, 45%) was prepared from the general
procedure (ethyl acetate/petroleum ether = 1:300 → 1:80, v/v) as a
1
yellow solid: mp = 50−52 °C; H NMR (500 MHz, CDCl3) δ 8.10
(dd, J = 8.2, 1.8 Hz, 2H), 8.03 (s, 1H), 7.75 (d, J = 1.4 Hz, 1H), 7.67
(q, J = 1.3 Hz, 1H), 7.56 (qd, J = 4.0, 1.6 Hz, 1H), 7.53−7.45 (m,
5H); 13C{1H} NMR (126 MHz, CDCl3) δ 158.7, 149.6, 148.9 (q,
2JC−F = 34 Hz), 139.2, 137.6, 135.4, 130.6, 130.0, 129.7, 128.9, 127.3,
1
MHz, CDCl3) δ 163.2 (d, JC−F = 246 Hz), 157.0, 161.3, 148.8 (q,
3
3
2JC−F = 34 Hz), 140.2 (d, JC−F = 8 Hz), 137.2, 130.4 (d, JC−F = 8
4
1
Hz), 129.9, 129.4, 127.2, 122.7 (d, JC−F = 3 Hz), 121.7 (q, JC−F
=
6428
J. Org. Chem. 2021, 86, 6423−6432